Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-09 Sale | 2022-12-13 4:18 pm | Repare Therapeutics Inc. | RPTX | Jerel Davis Director | 250,000 | $16 | $4,000,000 | 3,315,739 (Indirect Direct) | View |
| 2022-06-13 Purchase | 2022-06-15 6:15 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 149,161 | $12.73 | $1,898,820 | 412,604 (Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:37 pm | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:36 pm | Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:32 pm | Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,263,593 (Indirect Direct) | View |
| 2022-06-02 Purchase | 2022-06-06 6:14 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 1,836,958 | $11.9 | $21,859,329 | 406,436 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-20 6:09 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 420,000 | $8.5 | $3,570,000 | 313,357 (Direct) | View |
| 2022-03-15 Sale | 2022-03-16 4:04 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 533 | $11.3 | $6,023 | 46,041 (Direct) | View |
| 2022-01-19 Purchase | 2022-01-21 5:12 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 997,961 | $14.1 | $14,071,250 | 307,627 (Direct) | View |
| 2021-11-16 Purchase | 2021-11-18 5:00 pm | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 7,500 | $28.08 | $210,600 | 7,500 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 7:46 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 20,000 | $27.33 | $546,613 | 533 (Direct) | View |
| 2021-09-03 Sale | 2021-09-08 6:29 pm | Repare Therapeutics Inc. | RPTX | Bonita David P Director | 8,084 | $33.99 | $274,794 | 96,190 (Indirect) | View |
| 2021-09-03 Sale | 2021-09-08 6:18 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 8,084 | $33.99 | $274,794 | 96,190 (Indirect) | View |
| 2021-08-31 Sale | 2021-09-02 8:27 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) | View |
| 2021-08-31 Sale | 2021-09-02 8:20 pm | Repare Therapeutics Inc. | RPTX | Bonita David P Director | 37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) | View |
| 2021-08-26 Sale | 2021-08-30 6:37 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 18,073 | $34.07 | $615,748 | 97,542 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-30 Option Award | 2023-02-01 9:46 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 121,650 | $0 | 167,691 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:45 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 145,700 | $0 | 295,213 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:44 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO | 422,750 | $0 | 523,343 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:44 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 135,580 | $0 | 141,737 (Direct) | View |
| 2022-12-29 Other | 2023-01-03 4:38 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Jerel Davis Director | 468,099 | $0 | 2,823,613 (Indirect) | View |
| 2022-12-20 Exercise | 2022-12-20 8:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 51 | $2.425 | 305,179 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-20 8:05 pm | N/A 2029-05-01 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 48,507 | $0 | 305,179 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-20 8:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 48,456 | $2.062 | 305,179 (Direct) | View |
| 2022-06-06 Other | 2022-06-07 4:37 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 992,305 | $0 | 1,233,615 (Indirect) | View |
| 2022-06-06 Other | 2022-06-07 4:36 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner | 992,305 | $0 | 1,233,615 (Indirect) | View |
| 2022-06-06 Other | 2022-06-07 4:32 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner | 1,001,406 | $0 | 1,263,593 (Indirect) | View |
| 2022-05-13 Option Award | 2022-05-16 7:31 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:30 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:29 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:27 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Foley Todd Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:26 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Jerel Davis Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:25 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Morrison Briggs Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:24 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:23 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Bonita David P Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-01-21 Exercise(A) | 2022-01-24 4:55 pm | N/A 2032-01-20 | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:45 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:43 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:42 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:40 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 4:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 51 | $2.425 | 305,179 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 4:43 pm | N/A 2029-05-01 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 48,511 | $0 | 305,179 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 4:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 48,460 | $2.062 | 305,179 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 10,473 | $2.425 | 219,827 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,978 | $1.637 | 219,827 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A 2027-06-14 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 46,041 | $0 | 219,827 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 19,590 | $2.062 | 219,827 (Direct) | View |
Ownership | 2021-11-08 6:12 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 4,751,853 (Direct) | View |
| 2021-09-07 Option Award | 2021-09-09 5:06 pm | N/A 2031-09-07 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 42,000 | $0 | 42,000 (Direct) | View |